Dolby Laboratories (DLB) Projected to Announce Earnings on Thursday

Dolby Laboratories (NYSE:DLB) is expected to be posting its Q3 2026 results after the market closes on Thursday, July 30th. Analysts expect the company to announce earnings of $0.67 per share and revenue of $311.9590 million for the quarter. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earning summary page for the latest details on the call scheduled for Thursday, July 30, 2026 at 5:00 PM ET.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The business had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.34 EPS. On average, analysts expect Dolby Laboratories to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Dolby Laboratories Stock Up 3.0%

NYSE DLB opened at $51.36 on Tuesday. The company has a market cap of $4.86 billion, a PE ratio of 20.30 and a beta of 0.81. Dolby Laboratories has a 52 week low of $48.26 and a 52 week high of $76.70. The firm’s 50-day simple moving average is $52.30 and its two-hundred day simple moving average is $58.83.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on DLB shares. Barrington Research reissued an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research report on Monday, June 15th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Thursday, June 11th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Dolby Laboratories has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.

Insider Buying and Selling

In other Dolby Laboratories news, SVP John D. Couling sold 7,667 shares of Dolby Laboratories stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total transaction of $407,884.40. Following the completion of the transaction, the senior vice president owned 118,727 shares of the company’s stock, valued at $6,316,276.40. The trade was a 6.07% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CMO Todd Pendleton sold 11,876 shares of the company’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $54.55, for a total value of $647,835.80. Following the sale, the chief marketing officer owned 41,480 shares in the company, valued at approximately $2,262,734. This represents a 22.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 47,458 shares of company stock worth $2,639,537 over the last quarter. 37.93% of the stock is owned by corporate insiders.

Institutional Trading of Dolby Laboratories

Hedge funds and other institutional investors have recently bought and sold shares of the company. Aquatic Capital Management LLC bought a new position in Dolby Laboratories in the 3rd quarter valued at $56,000. iSAM Funds UK Ltd purchased a new stake in shares of Dolby Laboratories in the 3rd quarter valued at about $68,000. Quarry LP boosted its position in shares of Dolby Laboratories by 1,486.7% during the 4th quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after acquiring an additional 1,115 shares during the last quarter. Advisory Services Network LLC bought a new stake in shares of Dolby Laboratories during the 3rd quarter valued at about $102,000. Finally, US Bancorp DE grew its holdings in shares of Dolby Laboratories by 31.3% during the third quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock worth $103,000 after purchasing an additional 341 shares in the last quarter. Institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.